Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 11.7317.8312.958.485.93

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 11.73 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.73
Mar202517.83
Mar202412.95
Mar20238.48
Mar20225.93

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.73
-34.21
Mar2025 17.83
37.68
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹68,844.1 Cr -0.8% 6.5% 24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.8%

6.5%

24.5%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses